Joyonna Gamble-George
#175,981
Most Influential Person Now
Health researcher
Joyonna Gamble-George's AcademicInfluence.com Rankings
Joyonna Gamble-Georgephilosophy Degrees
Philosophy
#13153
World Rank
#18476
Historical Rank
#2635
USA Rank
Logic
#10485
World Rank
#13487
Historical Rank
#1996
USA Rank

Download Badge
Philosophy
Joyonna Gamble-George's Degrees
- PhD Public Health University of California, Berkeley
- Masters Epidemiology Stanford University
- Bachelors Biology University of California, Berkeley
Similar Degrees You Can Earn
Why Is Joyonna Gamble-George Influential?
(Suggest an Edit or Addition)According to Wikipedia, Joyonna Gamble-George is an American neuroscientist, innovator, and entrepreneur known for her research with the endocannabinoid system in stress-induced maladaptations of the brain. She is an Adjunct Professor at St. Petersburg College, Florida.
Joyonna Gamble-George's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity (2013) (250)
- Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation (2013) (117)
- Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation (2014) (105)
- Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation. (2014) (94)
- α-Synuclein Stimulates a Dopamine Transporter-dependent Chloride Current and Modulates the Activity of the Transporter* (2011) (74)
- Multiple Mechanistically Distinct Modes of Endocannabinoid Mobilization at Central Amygdala Glutamatergic Synapses (2014) (72)
- Chronic methamphetamine exposure produces a delayed, long‐lasting memory deficit (2013) (68)
- Sorafenib inhibits nuclear factor kappa B, decreases inducible nitric oxide synthase and cyclooxygenase-2 expression, and restores working memory in APPswe mice (2009) (62)
- HIV, Tat and dopamine transmission (2017) (43)
- Cyclooxygenase-2 inhibition reduces stress-induced affective pathology (2016) (42)
- Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice (2013) (33)
- Raf inhibition protects cortical cells against β-amyloid toxicity (2008) (16)
- HIV-Related Stigma Research as a Priority at the National Institutes of Health (2021) (16)
- Chronic Methamphetamine Increases Alpha-Synuclein Protein Levels in the Striatum and Hippocampus but not in the Cortex of Juvenile Mice. (2014) (15)
- ImPlementation REsearCh to DEvelop Interventions for People Living with HIV (the PRECluDE consortium): Combatting chronic disease comorbidities in HIV populations through implementation research. (2020) (11)
- In Parkinson's patient-derived dopamine neurons, the triplication of α-synuclein locus induces distinctive firing pattern by impeding D2 receptor autoinhibition (2021) (10)
- HIV‐1 Tat regulation of dopamine transmission and microglial reactivity is brain region specific (2018) (10)
- P2-319: Cotinine is neuroprotective against beta-amyloid toxicity (2008) (9)
- Alcohol Use Cravings as a Mediator Between Associated Risk Factors on Increased Alcohol Use among Youth Adults in New York During the COVID-19 Pandemic (2021) (7)
- Maternal Morbidity and Mortality: Are We Getting to the “Heart” of the Matter? (2020) (6)
- In Parkinson's patient-derived dopamine neurons, the triplication of α-synuclein locus induces distinctive firing pattern by impeding D2 receptor autoinhibition (2021) (3)
- Author response: Cyclooxygenase-2 inhibition reduces stress-induced affective pathology (2016) (2)
- Public Engagement with Biotechnology Inside and Outside the Classroom: Community-Focused Approaches. (2022) (0)
- Letter by Gamble-George et al Regarding Article, "Identification of Racial Inequities in Access to Specialized Inpatient Heart Failure Care at an Academic Medical Center". (2020) (0)
- P4-303: Sorafenib as a therapeutic agent against Alzheimer's disease (2008) (0)
- Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice (2013) (0)
- Methamphetamine exposure affects α‐synuclein expression in the cortex (2011) (0)
- Racial and ethnic differences in the association of social cohesion and social capital with HIV testing (2022) (0)
- Endocannabinoid augmentation through substrate-selective COX-2 inhibition: Behavioral and synaptic effects in an animal model of stress-induced anxiety (2016) (0)
This paper list is powered by the following services:
Other Resources About Joyonna Gamble-George
What Schools Are Affiliated With Joyonna Gamble-George?
Joyonna Gamble-George is affiliated with the following schools: